Telix Pharmaceuticals

TLXNasdaq Australia Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.903 B

$11.52 +8.27%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

338,777,049

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#67Viking TherapeuticsVKTX$4.00B
#68Tango TherapeuticsTNGX$3.92B
#69Telix PharmaceuticalsTLX$3.90B
#70Legend BiotechLEGN$3.85B
#71Structure TherapeuticsGPCR$3.78B

Where these numbers come from

Share counts and financials for Telix Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.